Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer (Q79400241)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 December 2006

Language	Label	Description	Also known as
English	Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer	scientific article published on 04 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Henry K Tsai

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

John J Coen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Anthony L Zietman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Donald S Kaufman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

William U Shipley

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

0 references

publication date

4 December 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

68

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1188-1192

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

The RAS signal transduction pathway and its role in radiation sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Therapy insight: Potential of statins for cancer chemoprevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

The potential of statins as part of anti-cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Cell cycle-specific effects of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Atorvastatin: a potential chemopreventive agent in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Rho GTPases: potential candidates for anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Implications for increased therapeutic ratio of low dose rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1078

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLOGY.2006.08.1078

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17141846%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79400241&oldid=1751589184"